Introduction:

Doctor of Medicine, associate professor, master's supervisor.

Prof. Wang is a visiting scholar of Mayo Clinic, member of Standing Committee of Chemotherapy Specialized Committee of Guangdong Provincial Anti-cancer Association, member of Holistic integrated Medicine of China Anti-Cancer Association, communication review expert of National Nature Science Foundation of China, Expert of Belt and Road Holistic Integrative Oncology Training Base (Guangdong) of China Anti-Cancer Association.

Prof. Wang has engaged in clinical practices and research of oncology for over 10 years, specialized in immunotherapy, targeted drugs, chemotherapy and management of toxic side efforts from treatments , cancer pain treatment, long-term survival guidance and management for patients with gastrointestinal tumors, such as colon-rectal cancer, gastric cancer, liver cancer, and esophageal cancer. She had participated in multiple international and domestic multi-center clinical trials of new anti-tumor drugs. Prof. 

Academic Achievements: 

Wang also is an expert consultant of “2022 Cross-hospital Communication of Standardized Treatment of Colon Cancer” of Healthy China 2023 (National Health Commission of the People’s Republic of China). She had hosted 7 municipal, provincial and national-level scientific research projects, the chief editor of Alleviative Treatment of Tumor, and an editorial member of Surgery of Gastric Cancer. As the Principle Investigator in sub-center, Prof. Wang undertook 9 clinical studies on Prof. Wang undertook 9 clinical studies on inoperable esophageal cancer, gastric cancer and intestinal cancer, etc.. 

Main research direction: 

Holistic and integrative medicine for gastrointestinal tumors.